Need more options? Click Here for Advanced Search!

EPA’s Final Hazardous Waste Pharmaceutical Rule: How to Comply for Prescription, Non-Prescription and Other Retail Items - On-Demand

EPA’s Final Hazardous Waste Pharmaceutical Rule: How to Comply for Prescription, Non-Prescription and Other Retail Items - On-Demand

Product Code: YNWA013119D

Availability: In stock

Internet Special:
Add Items to Cart

EPA’s Final Hazardous Waste Pharmaceutical Rule: How to Comply for Prescription, Non-Prescription and Other Retail Items - On-Demand

Webinar now available On-Demand.

WEBINAR SNAPSHOT: Learn how the EPA’s final hazardous waste pharmaceutical rule will impact your business operations and what you’ll need to do to comply and avoid fines.

Publication of the EPA’sfinal rule— now entitled “Management Standards for Hazardous Waste Pharmaceuticals and Amendment to the P075 Listing for Nicotine—to manage hazardous waste pharmaceuticals generated by healthcare facilities (including hospitals, clinics, and retail stores with pharmacies) and reverse distributors in the Federal Register is imminent. The rule will take effect 6 months after publication in the FR.

A significant component of the final rule is EPA’s de-listing of  FDA-approved, over-the-counter nicotine replacement therapies (e.g., nicotine patches, gum, and lozenges), which means these items will no longer be considered hazardous waste when discarded. A notable change from the proposed rule is EPA’s clarification and distinction between “reverse distribution” and “reverse logistics,” as well as an establishment of EPA’s policy on the regulatory status of unsold retail items, including nonprescription pharmaceuticals and other unsold retail items that have a reasonable expectation of being legitimately used/reused or reclaimed.

There will be plenty of questions about the practical impact it will have on business operations nationwide.

Use this on-demand, in-depth and informative webinar led by attorneys Greg Blount and Karlie Webb who will carefully assess the rule requirements and discuss the implications of the now final rule on both health care facilities and pharmaceutical reverse distributors. 

Attending this webinar will:

  • Eliminate the confusion associated with the numerous new requirements of the final hazardous waste pharmaceuticals rule
  • Provide tips to enable you to comply with the new rule
  • Clarify how the new rule will impact your business 
  • Enhance your understanding of the implications for retailers and reverse distributors
  • Inform you of the reactions to the final rule from industry professionals
  • Decrease the likelihood of making the common errors involved in any new set of rules


Register now to secure your seat at this timely webinar that will feature live Q&A with skilled environmental attorneys!

About Your Presenters

Greg BlountGreg Blount, Esq.
Troutman Sanders LLP

Greg Blount has broad experience representing clients in matters related to environmental law and policy for over 35 years, including related civil litigation and enforcement issues in state and federal courts. His experience includes work for retail chains, including pharmacies, on retail and pharmaceutical hazardous waste issues, as well as serving as national environmental counsel for a Fortune Top 10 company during extensive negotiations in California, Connecticut, Florida, Illinois, Kansas, and New Jersey.

Mr. Blount and his colleagues continue to remain very active in hazardous waste compliance and policy work at federal and state levels, particularly in California.

Karlie WebbKarlie Webb, Esq.
Troutman Sanders LLP 

Karlie Webb has a national practice, focusing on representing corporations, industry groups, and individuals in all aspects of environmental law, including regulatory compliance, rulemaking, and permitting, particularly under RCRA, CERCLA, and EPCRA. She also defends federal and state environmental enforcement actions and advises on facility-wide environmental compliance issues.

Ms. Webb commonly represents chain retailers, including grocers and pharmacies, among others, on retail and pharmaceutical hazardous waste issues, including advising on compliance with applicable federal and state regulatory schemes, permitting, and extensive negotiations with state environmental regulators to settle compliance claims.

    Write Your Own Review